Neurocrine Biosciences to Participate at Virtual Investor Conferences in March
![img: Featured](/wp-content/themes/neurocrine/assets/img/feature-5.jpg)
UBS Virtual CNS Day 2024 Conference on March 18 Stifel 2024 Virtual CNS Days Conference on March 19 SAN DIEGO , March 11, 2024 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will participate at two upcoming virtual investor conferences in March.